SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Aurobindo Pharma incorporates wholly owned subsidiary

22 Nov 2023 Evaluate

Aurobindo Pharma has incorporated a Wholly Owned Subsidiary (WoS) in the name of ‘Auro Trading’ on November 22, 2023. Auro Trading is incorporated for carrying on trading in generic formulations business.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.

Aurobindo Pharma Share Price

1551.45 -1.35 (-0.09%)
02-Jul-2026 13:30 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1869.75
Dr. Reddys Labs. 1354.20
Cipla 1458.10
Zydus Lifesciences 1097.75
Lupin 2390.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: